SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page Number PART I. FINANCIAL INFORMATION] [CERTIFICATION I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer EX-32.1 5 v166458_ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 6 v166458_ex32-2.htm]

By | 2016-03-01T06:57:32+00:00 November 16th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page Number

[SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page Number PART I. FINANCIAL INFORMATION] [CERTIFICATION I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer EX-32.1 5 v166458_ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 6 v166458_ex32-2.htm]

By | 2016-03-01T06:58:15+00:00 November 16th, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[Skystar Bio-Pharmaceutical Company Announces Third Quarter 2009 Financial Results Company Reports Record Quarterly Revenue of $12.78 Million and Adjusted Net Income of $4.25 Million; and Adjusted EPS of $0.61 Per Share XI'AN, CHINA – November 16, 2009 – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) THIRD QUARTER 2009 HIGHLIGHTS § Revenue increased 27.1% period over period to $12.78 million. § Gross margin]

By | 2016-03-01T06:59:07+00:00 November 16th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: Skystar Bio-Pharmaceutical Company Announces Third Quarter 2009 Financial

[Skystar Bio-Pharmaceutical Company Announces Third Quarter 2009 Financial Results Company Reports Record Quarterly Revenue of $12.78 Million and Adjusted Net Income of $4.25 Million; and Adjusted EPS of $0.61 Per Share XI'AN, CHINA – November 16, 2009 – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) THIRD QUARTER 2009 HIGHLIGHTS § Revenue increased 27.1% period over period to $12.78 million. § Gross margin]

By | 2016-03-01T06:59:42+00:00 November 16th, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

FFHL [Fuwei Films] 6-K: (Original Filing)

[Fuwei Films Announces Financial Results for Third Quarter of 2009 Teleconference to be Held on Friday, November 13, 2009 at 8:00 a.m. EST – BEIJING, November 13, 2009 Third Quarter 2009 Highlights § Revenues were RMB 89.6 million (US$13.1 million), compared with RMB 119.8 million in the same period of 2008 and RMB 72.0 million in the second quarter of] [EXPLANATORY NOTE On November 13 , 2009, the Company announced its unaudited consolidated financial results for the nine months period ended September 30, 2009. 2 FUWEI FILMS (HOLDINGS) CO., LTD. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2009 AND DECEMBER 31, 2008 (UNAUDITED) (amounts in thousands except share and per share value) September 30, 2009]

By | 2016-03-27T07:33:38+00:00 November 16th, 2009|Categories: Chinese Stocks, FFHL, SEC Original|Tags: , , , , , |0 Comments

FFHL [Fuwei Films] 6-K: Fuwei Films Announces Financial Results for Third Quarter

[Fuwei Films Announces Financial Results for Third Quarter of 2009 Teleconference to be Held on Friday, November 13, 2009 at 8:00 a.m. EST – BEIJING, November 13, 2009 Third Quarter 2009 Highlights § Revenues were RMB 89.6 million (US$13.1 million), compared with RMB 119.8 million in the same period of 2008 and RMB 72.0 million in the second quarter of] [EXPLANATORY NOTE On November 13 , 2009, the Company announced its unaudited consolidated financial results for the nine months period ended September 30, 2009. 2 FUWEI FILMS (HOLDINGS) CO., LTD. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2009 AND DECEMBER 31, 2008 (UNAUDITED) (amounts in thousands except share and per share value) September 30, 2009]

By | 2016-03-27T07:34:47+00:00 November 16th, 2009|Categories: Chinese Stocks, FFHL, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar